Showing results (381-390 of 391) with videos related to

Sort By:
Pageof 40
Annals of the Rheumatic Diseases|May 21, 2015
A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis riskAntonio Julià, José Antonio Pinto, Jordi Gratacós, et al.
Ophthalmology|April 1, 2018
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's DiseaseJosé Luis Martín-Varillas, Vanesa Calvo-Río, Emma Beltrán, et al.
Rheumatology (Oxford, England)|March 29, 2016
Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus RegistryJosé María Pego-Reigosa, Ana Lois-Iglesias, Íñigo Rúa-Figueroa, et al.
Rheumatology (Oxford, England)|July 6, 2014
Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patientsVanesa Calvo-Río, Ricardo Blanco, Emma Beltrán, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasisAdrià Aterido, Juan D Cañete, Jesús Tornero, et al.
Clinical and Experimental Rheumatology|May 23, 2020
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practiceMónica Calderón-Goercke, Santos Castañeda, Vicente Aldasoro, et al.
Seminars in Arthritis and Rheumatism|January 19, 2019
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practiceMónica Calderón-Goercke, Javier Loricera, Vicente Aldasoro, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2019
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 CasesBelén Atienza-Mateo, José Luis Martín-Varillas, Vanesa Calvo-Río, et al.
RMD Open|March 19, 2026
Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature reviewVanesa Calvo-Río, Carmen Secada-Gómez, Adrián Martín Gutiérrez, et al.
Rheumatology (Oxford, England)|October 17, 2020
Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patientsCarlos Fernández-Díaz, Santos Castañeda, Rafael B Melero-González, et al.
Pageof 40